Chromosome aberrations in solid tumors
暂无分享,去创建一个
D. Albertson | J. Gray | C. Collins | F. McCormick | J. Gray
[1] R T Schimke,et al. Gene amplification and drug resistance in cultured murine cells. , 1978, Science.
[2] G R Stark,et al. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. , 1979, The Journal of biological chemistry.
[3] J. Stephenson,et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.
[4] H. Varmus,et al. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[5] T. P. Dryja,et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.
[6] H. Sather,et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.
[7] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[8] B. Dutrillaux,et al. Cytogenetics of colorectal adenocarcinomas. , 1990, Cancer genetics and cytogenetics.
[9] R. Myers,et al. Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.
[10] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[11] Robin C. Allshire,et al. Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.
[12] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[13] M. Wigler,et al. Cloning the differences between two complex genomes , 1993, Science.
[14] B. Emanuel,et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.
[15] R. Weinberg,et al. Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] B. Ponder,et al. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. , 1994, Genes, chromosomes & cancer.
[17] J. Biegel,et al. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.
[18] C. James,et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. , 1994, Cancer research.
[19] V. Chapman,et al. Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning. , 1994, DNA research : an international journal for rapid publication of reports on genes and genomes.
[20] P. Meltzer,et al. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection , 1994, Nature Genetics.
[21] B. Dutrillaux,et al. Predominance of normal karyotype in colorectal tumors from hereditary non‐polyposis colorectal cancer patients , 1995, Genes, chromosomes & cancer.
[22] H. Scherthan,et al. Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error ' , 2006 .
[23] G. Hannon,et al. Deletion of the p16 and p15 genes in human bladder tumors. , 1995, Journal of the National Cancer Institute.
[24] J. Olson,et al. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. , 1995, Cancer research.
[25] B. Dutrillaux,et al. DNA‐repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements , 1995, Genes, chromosomes & cancer.
[26] D. Pinkel,et al. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. , 1995, Genes & development.
[27] J. Bartek,et al. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. , 1995, Cancer research.
[29] S. Kern,et al. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Ledbetter,et al. Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.
[31] A. Kurt,et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.
[32] David Sidransky,et al. Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.
[33] Thomas Ried,et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.
[34] Michael R. Speicher,et al. The coloring of cytogenetics , 1996, Nature Medicine.
[35] C. Boland,et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. , 1996, Cancer research.
[36] J. Bartek,et al. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. , 1996, Cancer research.
[37] Kazuhiro Yoshida,et al. Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates , 1996, International journal of cancer.
[38] M. Greaves. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? , 1996, Trends in genetics : TIG.
[39] J. Inazawa,et al. Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer , 1996, Cancer.
[40] O. Kallioniemi,et al. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. , 1997, The American journal of pathology.
[41] J Isola,et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.
[42] D. Birnbaum,et al. Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. , 1997, Cytogenetics and cell genetics.
[43] D. Morris,et al. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene. , 1997, Virology.
[44] A. Schäffer,et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.
[45] P. Lichter. Multicolor FISHing: what's the catch? , 1997, Trends in genetics : TIG.
[46] S. Roka,et al. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. , 1997, Chest.
[47] H. Döhner,et al. Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.
[48] D. Johnston,et al. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[49] J Isola,et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. , 1997, Cancer research.
[50] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[51] T. Anantharaman,et al. Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] C. Poremba,et al. Telomerase activity in human proliferative breast lesions. , 1998, International journal of oncology.
[53] Bert Vogelstein,et al. Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.
[54] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[55] Steinbeck Rg. Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. , 1998 .
[56] James M. Roberts,et al. The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.
[57] R. Steinbeck. Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. , 1998, British Journal of Cancer.
[58] J. Rowley,et al. The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.
[59] P. O’Connell,et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.
[60] F. Marshall,et al. Diagnosis of renal cancer by molecular urinalysis. , 1999, Journal of the National Cancer Institute.
[61] B. Dutrillaux,et al. TP53 status and gene amplification in human colorectal carcinomas. , 1999, Cancer genetics and cytogenetics.
[62] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[63] S. Elledge,et al. Cyclin D- and E-Dependent Kinases and the p57KIP2 Inhibitor: Cooperative Interactions In Vivo , 1999, Molecular and Cellular Biology.
[64] B. Scheithauer,et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.
[65] S. P. Fodor,et al. High density synthetic oligonucleotide arrays , 1999, Nature Genetics.
[66] J. Haber. DNA recombination: the replication connection. , 1999, Trends in biochemical sciences.
[67] M. Speicher,et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[68] F. Waldman,et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. , 1999, The American journal of pathology.
[69] D. Pinkel,et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.
[70] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[71] J. Rüschoff,et al. Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects. , 1999, Biochimica et biophysica acta.
[72] W. Kuo,et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.
[73] S. Devries,et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.
[74] M. Merchant,et al. A rapid protein profiling system that speeds study of cancer and other diseases. , 2000, American clinical laboratory.
[75] P. May,et al. Cell cycle control and cancer. , 2000, Pathologie-biologie.
[76] A. Balmain,et al. Allele‐specific loss or imbalance of chromosomes 9, 15, and 16 in B‐cell tumors from interspecific F1 hybrid mice carrying eμ‐c‐myc or N‐myc transgenes , 2000, International journal of cancer.
[77] Y. Chen,et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. , 2000, Journal of the National Cancer Institute.
[78] R. Jenkins,et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.
[79] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[80] S. Knuutila,et al. Online access to CGH data of DNA sequence copy number changes. , 2000, The American journal of pathology.
[81] J. Kononen,et al. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. , 2000, Cancer research.
[82] J W Gray,et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. , 2000, Cancer research.
[83] G. Levi,et al. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4 , 2000, Oncogene.
[84] R. DePinho,et al. A critical role for telomeres in suppressing and facilitating carcinogenesis. , 2000, Current opinion in genetics & development.
[85] Emanuel Petricoin,et al. Molecular profiling of human cancer , 2000, Nature Reviews Genetics.
[86] S. Elledge,et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. , 2000, Genes & development.
[87] T. Godfrey,et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.
[88] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[89] W. Gerald,et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells , 2001, Nature.
[90] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[91] R. DePinho,et al. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans , 2001, Nature Genetics.
[92] W. Hahn,et al. Derivation of human tumor cells in vitro without widespread genomic instability. , 2001, Cancer research.
[93] C. Fauth,et al. Classifying by colors: FISH-based genome analysis , 2001, Cytogenetic and Genome Research.
[94] D. Schild,et al. Homologous recombinational repair of DNA ensures mammalian chromosome stability. , 2001, Mutation research.
[95] K. Khanna,et al. ATM, a central controller of cellular responses to DNA damage , 2001, Cell Death and Differentiation.
[96] E. Petricoin,et al. Cancer proteomics: from biomarker discovery to signal pathway profiling. , 2001, Cancer journal.
[97] Thomas D. Schmittgen,et al. Real-Time Quantitative PCR , 2002 .
[98] P. Jallepalli,et al. Chromosome segregation and cancer: cutting through the mystery , 2001, Nature Reviews Cancer.
[99] D. Botstein,et al. Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF , 2001, Nature.
[100] Jeremy M. Stark,et al. Double-strand breaks and tumorigenesis. , 2001, Trends in cell biology.
[101] P. N. Rao,et al. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.
[102] E. Petricoin,et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.
[103] Richard D. Wood,et al. Human DNA Repair Genes , 2001, Science.
[104] L. Liotta,et al. Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.
[105] Petricoin Ef rd,et al. Cancer proteomics: from biomarker discovery to signal pathway profiling. , 2001, Cancer journal.
[106] W. Hanna. Testing for HER2 Status , 2001, Oncology.
[107] A. Berns,et al. Haplo-insufficiency? Let me count the ways. , 2001, Genes & development.
[108] S. Devries,et al. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[109] P. Edwards,et al. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[110] L. Aaltonen,et al. Comparison of Serous and Mucinous Ovarian Carcinomas: Distinct Pattern of Allelic Loss at Distal 8p and Expression of Transcription Factor GATA-4 , 2001, Laboratory Investigation.
[111] Ajay N. Jain,et al. Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.
[112] Joe W. Gray,et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas , 2001, Nature Genetics.
[113] J. Hoeijmakers,et al. Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.
[114] Debabrata Banerjee,et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. , 2002, Biochimica et biophysica acta.
[115] K. Haigis,et al. Intestinal adenomas can develop with a stable karyotype and stable microsatellites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[116] S. Artandi. Telomere shortening and cell fates in mouse models of neoplasia. , 2002, Trends in molecular medicine.
[117] Martin Lipkin,et al. Migrating colonic crypt epithelial cells: primary targets for transformation. , 2002, Carcinogenesis.
[118] T. Hoang,et al. Gradient of E2A Activity in B-Cell Development , 2002, Molecular and Cellular Biology.
[119] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[120] Erich A. Nigg,et al. Centrosome aberrations: cause or consequence of cancer progression? , 2002, Nature Reviews Cancer.
[121] D. Schild,et al. Recombinational DNA repair and human disease. , 2002, Mutation research.
[122] Ajay N. Jain,et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. , 2002, Cancer research.
[123] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[124] W. Lingle,et al. Centrosome amplification and the development of cancer , 2002, Oncogene.
[125] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[126] M. Ringnér,et al. Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.
[127] M. Morrow,et al. Chemoprevention of breast cancer: a model for change. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] G. Evan,et al. Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.
[129] O. Olopade,et al. Cyclin D1 Amplification and p16(MTS1/CDK4I) Deletion Correlate With Poor Prognosis in Head and Neck Tumors , 2002, The Laryngoscope.
[130] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[131] Marcel J T Reinders,et al. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. , 2002, Cancer research.
[132] G. Boivin,et al. Enhanced Tumor Formation in Mice Heterozygous for Blm Mutation , 2002, Science.
[133] T. Lange. Protection of mammalian telomeres , 2002, Oncogene.
[134] M. Robinson,et al. Telomere dysfunction: multiple paths to the same end , 2002, Oncogene.
[135] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[136] C. Bloomfield,et al. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. , 2002, International journal of oncology.
[137] M. Koshiji,et al. Microsatellite analysis of fecal DNA for colorectal cancer detection * , 2002, Journal of surgical oncology.
[138] J. Baselga. Why the epidermal growth factor receptor? The rationale for cancer therapy. , 2002, The oncologist.
[139] J. Shay,et al. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. , 2002, Differentiation; research in biological diversity.
[140] D. Medina. Biological and molecular characteristics of the premalignant mouse mammary gland. , 2002, Biochimica et biophysica acta.
[141] R. Dahse,et al. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[142] Kyoung-Mee Kim,et al. Methylation reveals a niche: stem cell succession in human colon crypts , 2002, Oncogene.
[143] Bert Vogelstein,et al. Allelic Variation in Human Gene Expression , 2002, Science.
[144] Cestmir Vlcek,et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers , 2002, Nature Genetics.
[145] J. Baselga,et al. HER-Targeted Tyrosine-Kinase Inhibitors , 2002, Oncology.
[146] J. Mendelsohn. Targeting the epidermal growth factor receptor for cancer therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[147] M. Winey,et al. Centrosomes and tumour suppressors. , 2002, Current opinion in cell biology.
[148] M. Gerstein,et al. GATA-1 binding sites mapped in the β-globin locus by using mammalian chIp-chip analysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[149] A. Balmain. Cancer: New-age tumour suppressors , 2002, Nature.
[150] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[151] R. Reddel,et al. Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.
[152] E. Gabrielson,et al. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. , 2002, The American journal of pathology.
[153] C. Deng,et al. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer , 2002, Oncogene.
[154] O. Sieber,et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[155] A. Sparks,et al. Using the transcriptome to annotate the genome , 2002, Nature Biotechnology.
[156] Colin C. Collins,et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors , 2002, Nature Genetics.
[157] Kim Nasmyth,et al. Segregating Sister Genomes: The Molecular Biology of Chromosome Separation , 2002, Science.
[158] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[159] R. DePinho,et al. Connecting chromosomes, crisis, and cancer. , 2002, Science.
[160] Lyndsay N Harris,et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[161] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[162] P. Cutler. Protein arrays: The current state‐of‐the‐art , 2003, Proteomics.
[163] Jane Fridlyand,et al. Shaping of tumor and drug-resistant genomes by instability and selection , 2003, Oncogene.
[164] H. Ireland,et al. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma. , 2003, Cancer research.
[165] K. Haigis,et al. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity , 2003, Nature Genetics.
[166] Daniela S Krause,et al. Tyrosine kinases as targets for cancer therapy. , 2005, The New England journal of medicine.